BLUENERGIES LTD (BLU.CA) Stock News

Canada - Toronto Stock Exchange - TSX:BLU - CA0959221007 - Common Stock

1 CAD

+0.1 (+11.11%)

Last: 11/24/2025, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BLU.CA Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders

3 years ago - By: BELLUS Health Inc. - Mentions: BLU GSK

BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Announces Meeting Updates

3 years ago - By: BELLUS Health Inc. - Mentions: BLU GSK

GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

3 years ago - By: Bloomberg

GSK to Buy Bellus for $2 Billion to Gain Cough Medicine

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Reports Year 2022 Financial Results and Business Highlights

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Present on the Patient Experience and the Burden of Refractory Chronic Cough at the American Academy of Allergy, Asthma & Immunology Annual Meeting

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Present at the H.C. Wainwright Global Investment Conference

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the European Respiratory Society International Congress 2022

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Participate in the William Blair Biotech Focus Conference

3 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Participate in the Jefferies Healthcare Conference

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Participate in Multiple Upcoming Investor Conferences

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Reports Year 2021 Financial Results and Business Highlights

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the United States

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Convenes Virtual Analyst Event to Discuss the Chronic Cough Landscape and its Selective P2X3 Antagonist BLU-5937

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Announces Completion of Patient Enrollment in SOOTHE Phase 2b Trial for Refractory Chronic Cough and BLUEPRINT Phase 2a Trial for Chronic Pruritus Associated with Atopic Dermatitis

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Present at the H.C. Wainwright Global Investment Conference

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Report Additional RELIEF Data in an Oral Presentation at the European Respiratory Society International Congress 2021

4 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health Reports Second Quarter 2021 Financial Results and Business Highlights

5 years ago - By: BELLUS Health Inc. - Mentions: BLU

BELLUS Health to Participate in the Jefferies Virtual Healthcare Conference